Birchcreek Wealth Management, LLC Bio N Tech Se Transaction History

Birchcreek Wealth Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 06, 2023	SELL	$118.43 - $186.05 $8,290 - $13,023	-70 Reduced 4.38%	1,527 $229,000
Q3 2022 Nov 14, 2022	SELL	$127.65 - $183.11 $19,147 - $27,466	-150 Reduced 8.59%	1,597 $215,000
Q2 2022 Aug 12, 2022	BUY	$123.25 - $186.24 $3,081 - $4,656	25 Added 1.45%	1,747 $260,000
Q1 2022 May 13, 2022	BUY	$126.25 - $231.85 $34,718 - $63,758	275 Added 19.0%	1,722 $294,000
Q4 2021 Feb 09, 2022	BUY	$216.64 - $362.52 $51,993 - $87,004	240 Added 19.88%	1,447 $373,000
Q3 2021 Nov 16, 2021	SELL	$205.93 - $447.23 $60,955 - $132,380	-296 Reduced 19.69%	1,207 $329,000
Q2 2021 Aug 16, 2021	BUY	$113.32 - $241.49 $170,319 - $362,959	1,503 New	1,503 $336,000
Q1 2021 May 17, 2021	SELL	$85.73 - $119.5 $133,481 - $186,061	-1,557 Closed	0 $0
Q4 2020 Jan 28, 2021	BUY	$72.71 - $129.54 $113,209 - $201,693	1,557 New	1,557 $126,000

358

38.4M

2.45M

2.29M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $24.2B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Birchcreek Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Birchcreek Wealth Management, LLC with notifications on news.